{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T07:46:47Z","timestamp":1775980007355,"version":"3.50.1"},"reference-count":79,"publisher":"Oxford University Press (OUP)","issue":"Supplement_1","license":[{"start":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T00:00:00Z","timestamp":1594598400000},"content-version":"vor","delay-in-days":12,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R35GM124952"],"award-info":[{"award-number":["R35GM124952"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Motivation<\/jats:title>\n                    <jats:p>Combination therapy has shown to improve therapeutic efficacy while reducing side effects. Importantly, it has become an indispensable strategy to overcome resistance in antibiotics, antimicrobials and anticancer drugs. Facing enormous chemical space and unclear design principles for small-molecule combinations, computational drug-combination design has not seen generative models to meet its potential to accelerate resistance-overcoming drug combination discovery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We have developed the first deep generative model for drug combination design, by jointly embedding graph-structured domain knowledge and iteratively training a reinforcement learning-based chemical graph-set designer. First, we have developed hierarchical variational graph auto-encoders trained end-to-end to jointly embed gene\u2013gene, gene\u2013disease and disease\u2013disease networks. Novel attentional pooling is introduced here for learning disease representations from associated genes\u2019 representations. Second, targeting diseases in learned representations, we have recast the drug-combination design problem as graph-set generation and developed a deep learning-based model with novel rewards. Specifically, besides chemical validity rewards, we have introduced novel generative adversarial award, being generalized sliced Wasserstein, for chemically diverse molecules with distributions similar to known drugs. We have also designed a network principle-based reward for disease-specific drug combinations. Numerical results indicate that, compared to state-of-the-art graph embedding methods, hierarchical variational graph auto-encoder learns more informative and generalizable disease representations. Results also show that the deep generative models generate drug combinations following the principle across diseases. Case studies on four diseases show that network-principled drug combinations tend to have low toxicity. The generated drug combinations collectively cover the disease module similar to FDA-approved drug combinations and could potentially suggest novel systems pharmacology strategies. Our method allows for examining and following network-based principle or hypothesis to efficiently generate disease-specific drug combinations in a vast chemical combinatorial space.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Availability and implementation<\/jats:title>\n                    <jats:p>https:\/\/github.com\/Shen-Lab\/Drug-Combo-Generator.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Supplementary information<\/jats:title>\n                    <jats:p>Supplementary data are available at Bioinformatics online.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/bioinformatics\/btaa317","type":"journal-article","created":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T07:24:54Z","timestamp":1588145094000},"page":"i445-i454","source":"Crossref","is-referenced-by-count":34,"title":["Network-principled deep generative models for designing drug combinations as graph sets"],"prefix":"10.1093","volume":"36","author":[{"given":"Mostafa","family":"Karimi","sequence":"first","affiliation":[{"name":"Department of Electrical and Computer Engineering"},{"name":"TEES\u2013AgriLife Center for Bioinformatics and Genomic Systems Engineering, Texas A&M University , College Station, TX 77843, USA"}]},{"given":"Arman","family":"Hasanzadeh","sequence":"additional","affiliation":[{"name":"Department of Electrical and Computer Engineering"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1703-7796","authenticated-orcid":false,"given":"Yang","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Electrical and Computer Engineering"},{"name":"TEES\u2013AgriLife Center for Bioinformatics and Genomic Systems Engineering, Texas A&M University , College Station, TX 77843, USA"}]}],"member":"286","published-online":{"date-parts":[[2020,7,13]]},"reference":[{"key":"2024021913375054800_btaa317-B1","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/146837a0","article-title":"An enzyme from bacteria able to destroy penicillin","volume":"146","author":"Abraham","year":"1940","journal-title":"Nature"},{"key":"2024021913375054800_btaa317-B2","doi-asserted-by":"crossref","first-page":"D525","DOI":"10.1093\/nar\/gkp878","article-title":"The intact molecular interaction database in 2010","volume":"38","author":"Aranda","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"2024021913375054800_btaa317-B3","first-page":"214","author":"Arjovsky","year":"2017"},{"key":"2024021913375054800_btaa317-B4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/75556","article-title":"Gene ontology: tool for the unification of biology","volume":"25","author":"Ashburner","year":"2000","journal-title":"Nat. Genet"},{"key":"2024021913375054800_btaa317-B5","doi-asserted-by":"crossref","first-page":"e00499","DOI":"10.7554\/eLife.00499","article-title":"Overcoming mutation-based resistance to antiandrogens with rational drug design","volume":"2","author":"Balbas","year":"2013","journal-title":"Elife"},{"key":"2024021913375054800_btaa317-B6","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1158\/1078-0432.CCR-14-1814","article-title":"A phase Ib dose-escalation study of the oral pan-PI3K inhibitor buparlisib (BKM120) in combination with the oral MEK1\/2 inhibitor trametinib (GSK1120212) in patients with selected advanced solid tumors","volume":"21","author":"Bedard","year":"2015","journal-title":"Clin. Cancer Res"},{"key":"2024021913375054800_btaa317-B7","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/cpa.3160370503","article-title":"The inversion problem and applications of the generalized Radon transform","volume":"37","author":"Beylkin","year":"1984","journal-title":"Commun. Pure Appl. Math"},{"key":"2024021913375054800_btaa317-B8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/(SICI)1098-1128(199601)16:1<3::AID-MED1>3.0.CO;2-6","article-title":"The art and practice of structure-based drug design: a molecular modeling perspective","volume":"16","author":"Bohacek","year":"1996","journal-title":"Med. Res. Rev"},{"key":"2024021913375054800_btaa317-B9","doi-asserted-by":"crossref","first-page":"e00747","DOI":"10.7554\/eLife.00747","article-title":"Evolutionary dynamics of cancer in response to targeted combination therapy","volume":"2","author":"Bozic","year":"2013","journal-title":"Elife"},{"key":"2024021913375054800_btaa317-B10","doi-asserted-by":"crossref","first-page":"D532","DOI":"10.1093\/nar\/gkp983","article-title":"Mint, the molecular interaction database: 2009 update","volume":"38","author":"Ceol","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"2024021913375054800_btaa317-B11","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1126\/science.293.5536.1793","article-title":"Structure of MsbA from E. coli: a homolog of the multidrug resistance ATP binding cassette (ABC) transporters","volume":"293","author":"Chang","year":"2001","journal-title":"Science"},{"key":"2024021913375054800_btaa317-B12","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/s41467-019-09186-x","article-title":"Network-based prediction of drug combinations","volume":"10","author":"Cheng","year":"2019","journal-title":"Nat. Commun"},{"key":"2024021913375054800_btaa317-B13","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies","volume":"58","author":"Chou","year":"2006","journal-title":"Pharmacol. Rev"},{"key":"2024021913375054800_btaa317-B14","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res"},{"key":"2024021913375054800_btaa317-B15","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1056\/NEJMra025195","article-title":"HIV drug resistance","volume":"350","author":"Clavel","year":"2004","journal-title":"N. Engl. J. Med"},{"key":"2024021913375054800_btaa317-B16","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1093\/bioinformatics\/btp163","article-title":"Biopython: freely available python tools for computational molecular biology and bioinformatics","volume":"25","author":"Cock","year":"2009","journal-title":"Bioinformatics"},{"key":"2024021913375054800_btaa317-B17","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/j.ejmech.2010.01.002","article-title":"Support vector machines: development of QSAR models for predicting anti-HIV-1 activity of TIBO derivatives","volume":"45","author":"Darnag","year":"2010","journal-title":"Eur. J. Med. Chem"},{"key":"2024021913375054800_btaa317-B18","doi-asserted-by":"crossref","first-page":"4265","DOI":"10.1021\/acs.jmedchem.8b01610","article-title":"A survey of the structures of US FDA approved combination drugs","volume":"62","author":"Das","year":"2019","journal-title":"J. Med. Chem"},{"key":"2024021913375054800_btaa317-B19","doi-asserted-by":"crossref","first-page":"D948","DOI":"10.1093\/nar\/gky868","article-title":"The comparative toxicogenomics database: update 2019","volume":"47","author":"Davis","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"2024021913375054800_btaa317-B20","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s13073-016-0369-x","article-title":"Approaches to modernize the combination drug development paradigm","volume":"8","author":"Day","year":"2016","journal-title":"Genome Med"},{"key":"2024021913375054800_btaa317-B21","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jhealeco.2016.01.012","article-title":"Innovation in the pharmaceutical industry: new estimates of R&D costs","volume":"47","author":"DiMasi","year":"2016","journal-title":"J. Health Econ"},{"key":"2024021913375054800_btaa317-B22","doi-asserted-by":"crossref","first-page":"257","DOI":"10.7326\/0003-4819-117-3-257","article-title":"Multidrug-resistant tuberculosis","volume":"117","author":"Dooley","year":"1992","journal-title":"Ann. Int. Med"},{"key":"2024021913375054800_btaa317-B23","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.2174\/13816128113199990066","article-title":"Network-based strategies can help mono-and poly-pharmacology drug discovery: a systems biology view","volume":"20","author":"Engin","year":"2014","journal-title":"Curr. Pharm. Des"},{"key":"2024021913375054800_btaa317-B24","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1056\/NEJMoa1210093","article-title":"Combined BRAF and MEK inhibition in melanoma with BRAF v600 mutations","volume":"367","author":"Flaherty","year":"2012","journal-title":"N. Engl. J. Med"},{"key":"2024021913375054800_btaa317-B25","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1053\/j.gastro.2007.02.039","article-title":"Drug targets and molecular mechanisms of drug resistance in chronic hepatitis B","volume":"132","author":"Ghany","year":"2007","journal-title":"Gastroenterology"},{"key":"2024021913375054800_btaa317-B26","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1145\/2939672.2939754","article-title":"node2vec: scalable feature learning for networks","author":"Grover","year":"2016","journal-title":"Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining"},{"key":"2024021913375054800_btaa317-B27","first-page":"5767","article-title":"Improved training of Wasserstein GANs","author":"Gulrajani","year":"2017","journal-title":"Advances in Neural Information Processing Systems"},{"key":"2024021913375054800_btaa317-B28","first-page":"10700","article-title":"Variational graph recurrent neural networks","author":"Hajiramezanali","year":"2019","journal-title":"Advances in Neural Information Processing Systems"},{"key":"2024021913375054800_btaa317-B29","doi-asserted-by":"crossref","first-page":"D514","DOI":"10.1093\/nar\/gki033","article-title":"Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders","volume":"33","author":"Hamosh","year":"2005","journal-title":"Nucleic Acids Research"},{"key":"2024021913375054800_btaa317-B30","first-page":"10711","article-title":"Semi-implicit graph variational auto-encoders","author":"Hasanzadeh","year":"2019","journal-title":"Advances in Neural Information Processing Systems"},{"key":"2024021913375054800_btaa317-B31","doi-asserted-by":"crossref","first-page":"e1000353","DOI":"10.1371\/journal.pcbi.1000353","article-title":"A dynamic network approach for the study of human phenotypes","volume":"5","author":"Hidalgo","year":"2009","journal-title":"PLoS Comput. Biol"},{"key":"2024021913375054800_btaa317-B32","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/nrc3599","article-title":"Cancer drug resistance: an evolving paradigm","volume":"13","author":"Holohan","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"2024021913375054800_btaa317-B33","doi-asserted-by":"crossref","first-page":"D261","DOI":"10.1093\/nar\/gkr1122","article-title":"Phosphositeplus: a comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse","volume":"40","author":"Hornbeck","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"2024021913375054800_btaa317-B34","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.3390\/cancers6031769","article-title":"Drug resistance in cancer: an overview","volume":"6","author":"Housman","year":"2014","journal-title":"Cancers"},{"key":"2024021913375054800_btaa317-B35","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1021\/ci049714+","article-title":"Zinc- a free database of commercially available compounds for virtual screening","volume":"45","author":"Irwin","year":"2005","journal-title":"J. Chem. Inf. Model"},{"key":"2024021913375054800_btaa317-B36","first-page":"91","volume-title":"Novartis Foundation Symposium","author":"Kanehisa","year":"2002"},{"key":"2024021913375054800_btaa317-B37","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0764-4469(00)01252-X","article-title":"Genomics and medicine: an anticipation","volume":"323","author":"Kaplan","year":"2000","journal-title":"C. R. Acad. Sci"},{"key":"2024021913375054800_btaa317-B38","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1093\/bioinformatics\/btz111","article-title":"DeepAffinity: interpretable deep learning of compound\u2013protein affinity through unified recurrent and convolutional neural networks","volume":"35","author":"Karimi","year":"2019","journal-title":"Bioinformatics"},{"key":"2024021913375054800_btaa317-B39","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nrd1609","article-title":"Multicomponent therapeutics for networked systems","volume":"4","author":"Keith","year":"2005","journal-title":"Nat. Rev. Drug Discov"},{"key":"2024021913375054800_btaa317-B40","doi-asserted-by":"crossref","first-page":"D767","DOI":"10.1093\/nar\/gkn892","article-title":"Human protein reference database-2009 update","volume":"37","author":"Keshava Prasad","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"2024021913375054800_btaa317-B41","author":"Kipf","year":"2016"},{"key":"2024021913375054800_btaa317-B42","first-page":"261","author":"Kolouri","year":"2019"},{"key":"2024021913375054800_btaa317-B43","doi-asserted-by":"crossref","first-page":"9880","DOI":"10.1073\/pnas.0802208105","article-title":"The implications of human metabolic network topology for disease comorbidity","volume":"105","author":"Lee","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2024021913375054800_btaa317-B44","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1158\/1078-0432.CCR-13-1610","article-title":"Molecular pathways: resistance to kinase inhibitors and implications for therapeutic strategies","volume":"20","author":"Lovly","year":"2014","journal-title":"Clin. Cancer Res"},{"key":"2024021913375054800_btaa317-B45","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/bib\/bbw104","article-title":"Predictive approaches for drug combination discovery in cancer","volume":"19","author":"Madani Tonekaboni","year":"2018","journal-title":"Brief. Bioinform"},{"key":"2024021913375054800_btaa317-B46","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1080\/17460441.2016.1236786","article-title":"Should network biology be used for drug discovery?","volume":"11","author":"Mart\u00ednez-Jim\u00e9nez","year":"2016","journal-title":"Expert Opin. Drug Discov"},{"key":"2024021913375054800_btaa317-B47","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/nar\/gkg108","article-title":"Transfac\u00ae: transcriptional regulation, from patterns to profiles","volume":"31","author":"Matys","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"2024021913375054800_btaa317-B48","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3389\/fenvs.2015.00080","article-title":"DeepTox: toxicity prediction using deep learning","volume":"3","author":"Mayr","year":"2016","journal-title":"Front. Environ. Sci"},{"key":"2024021913375054800_btaa317-B49","doi-asserted-by":"crossref","first-page":"1257601","DOI":"10.1126\/science.1257601","article-title":"Uncovering disease-disease relationships through the incomplete interactome","volume":"347","author":"Menche","year":"2015","journal-title":"Science"},{"key":"2024021913375054800_btaa317-B50","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/1471-2105-9-S5-S3","article-title":"Mapping proteins to disease terminologies: from UniProt to MeSH","volume":"9","author":"Mottaz","year":"2008","journal-title":"BMC Bioinformatics"},{"key":"2024021913375054800_btaa317-B51","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1093\/bioinformatics\/btu046","article-title":"Combinatorial therapy discovery using mixed integer linear programming","volume":"30","author":"Pang","year":"2014","journal-title":"Bioinformatics"},{"key":"2024021913375054800_btaa317-B52","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1145\/2623330.2623732","article-title":"DeepWalk: online learning of social representations","author":"Perozzi","year":"2014","journal-title":"Proceedings of the 20th ACM SIGKDD International Conference on Knowledge Discovery and Data Mining"},{"key":"2024021913375054800_btaa317-B53","doi-asserted-by":"crossref","first-page":"eaap7885","DOI":"10.1126\/sciadv.aap7885","article-title":"Deep reinforcement learning for de novo drug design","volume":"4","author":"Popova","year":"2018","journal-title":"Sci. Adv"},{"key":"2024021913375054800_btaa317-B54","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1093\/bioinformatics\/btx806","article-title":"DeepSynergy: predicting anti-cancer drug synergy with deep learning","volume":"34","author":"Preuer","year":"2018","journal-title":"Bioinformatics"},{"key":"2024021913375054800_btaa317-B55","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1128\/AAC.00474-11","article-title":"Synergistic drug combinations for tuberculosis therapy identified by a novel high-throughput screen","volume":"55","author":"Ram\u00f3n-Garc\u00eda","year":"2011","journal-title":"Antimicrob. Agents Chemother"},{"key":"2024021913375054800_btaa317-B56","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/ejhg.2013.96","article-title":"Phenotype\u2013genotype integrator (PheGenI): synthesizing genome-wide association study (GWAS) data with existing genomic resources","volume":"22","author":"Ramos","year":"2014","journal-title":"Eur. J. Hum. Genet"},{"key":"2024021913375054800_btaa317-B57","first-page":"114","article-title":"Medical subject headings","volume":"51","author":"Rogers","year":"1963","journal-title":"Bull. Med. Libr. Assoc"},{"key":"2024021913375054800_btaa317-B58","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.cell.2014.10.050","article-title":"A proteome-scale map of the human interactome network","volume":"159","author":"Rolland","year":"2014","journal-title":"Cell"},{"key":"2024021913375054800_btaa317-B59","doi-asserted-by":"crossref","first-page":"D497","DOI":"10.1093\/nar\/gkp914","article-title":"CORUM: the comprehensive resource of mammalian protein complexes-2009","volume":"38","author":"Ruepp","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"2024021913375054800_btaa317-B60","doi-asserted-by":"crossref","first-page":"E4304","DOI":"10.1073\/pnas.1803294115","article-title":"Deep learning improves prediction of drug\u2013drug and drug\u2013food interactions","volume":"115","author":"Ryu","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2024021913375054800_btaa317-B61","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1158\/0008-5472.CAN-17-1201","article-title":"Combination therapy and the evolution of resistance: the theoretical merits of synergism and antagonism in cancer","volume":"78","author":"Saputra","year":"2018","journal-title":"Cancer Res"},{"key":"2024021913375054800_btaa317-B62","doi-asserted-by":"crossref","first-page":"D940","DOI":"10.1093\/nar\/gkr972","article-title":"Disease ontology: a backbone for disease semantic integration","volume":"40","author":"Schriml","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"2024021913375054800_btaa317-B63","author":"Schulman","year":"2017"},{"key":"2024021913375054800_btaa317-B64","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0753-3322(99)80063-8","article-title":"Highly active antiretroviral therapy (HAART) for the treatment of infection with human immunodeficiency virus type 1","volume":"53","author":"Shafer","year":"1999","journal-title":"Biomed. Pharmacother"},{"key":"2024021913375054800_btaa317-B65","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.cell.2015.03.030","article-title":"Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential","volume":"161","author":"Sharma","year":"2015","journal-title":"Cell"},{"key":"2024021913375054800_btaa317-B66","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/ja.2017.102","article-title":"Suppressive drug combinations and their potential to combat antibiotic resistance","volume":"70","author":"Singh","year":"2017","journal-title":"J. Antibiot"},{"key":"2024021913375054800_btaa317-B67","doi-asserted-by":"crossref","first-page":"D698","DOI":"10.1093\/nar\/gkq1116","article-title":"The biogrid interaction database: 2011 update","volume":"39","author":"Stark","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"2024021913375054800_btaa317-B68","doi-asserted-by":"crossref","first-page":"6062","DOI":"10.1073\/pnas.0400782101","article-title":"A gene atlas of the mouse and human protein-encoding transcriptomes","volume":"101","author":"Su","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2024021913375054800_btaa317-B69","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1021\/ci034160g","article-title":"Random forest: a classification and regression tool for compound classification and QSAR modeling","volume":"43","author":"Svetnik","year":"2003","journal-title":"J. Chem. Inf. Comput. Sci"},{"key":"2024021913375054800_btaa317-B70","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1126\/science.321.5887.356","article-title":"The bacteria fight back","volume":"321","author":"Taubes","year":"2008","journal-title":"Science"},{"key":"2024021913375054800_btaa317-B71","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1038\/ng.2822","article-title":"ESR1 ligand-binding domain mutations in hormone-resistant breast cancer","volume":"45","author":"Toy","year":"2013","journal-title":"Nat. Genet"},{"key":"2024021913375054800_btaa317-B72","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJMoa1505270","article-title":"Palbociclib in hormone-receptor\u2013positive advanced breast cancer","volume":"373","author":"Turner","year":"2015","journal-title":"N. Engl. J. Med"},{"key":"2024021913375054800_btaa317-B73","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jacbts.2016.03.002","article-title":"Drugs, devices, and the FDA: Part 1: an overview of approval processes for drugs","volume":"1","author":"Van Norman","year":"2016","journal-title":"JACC Basic Transl. Sci"},{"key":"2024021913375054800_btaa317-B74","doi-asserted-by":"crossref","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","article-title":"DrugBank 5.0: a major update to the DrugBank database for 2018","volume":"46","author":"Wishart","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"2024021913375054800_btaa317-B75","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/biostatistics\/kxx069","article-title":"Estimation of clinical trial success rates and related parameters","volume":"20","author":"Wong","year":"2019","journal-title":"Biostatistics"},{"key":"2024021913375054800_btaa317-B76","first-page":"6410","article-title":"Graph convolutional policy network for goal-directed molecular graph generation","author":"You","year":"2018","journal-title":"Advances in Neural Information Processing Systems"},{"key":"2024021913375054800_btaa317-B77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12859-018-2220-4","article-title":"Predicting drug-disease associations by using similarity constrained matrix factorization","volume":"19","author":"Zhang","year":"2018","journal-title":"BMC Bioinformatics"},{"key":"2024021913375054800_btaa317-B78","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/s41587-019-0224-x","article-title":"Deep learning enables rapid identification of potent DDR1 kinase inhibitors","volume":"37","author":"Zhavoronkov","year":"2019","journal-title":"Nat. Biotechnol"},{"key":"2024021913375054800_btaa317-B79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms5212","article-title":"Human symptoms\u2013disease network","volume":"5","author":"Zhou","year":"2014","journal-title":"Nat. Commun"}],"container-title":["Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article-pdf\/36\/Supplement_1\/i445\/56702592\/bioinformatics_36_supplement1_i445.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article-pdf\/36\/Supplement_1\/i445\/56702592\/bioinformatics_36_supplement1_i445.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T08:49:35Z","timestamp":1708332575000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article\/36\/Supplement_1\/i445\/5870465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,1]]},"references-count":79,"journal-issue":{"issue":"Supplement_1","published-print":{"date-parts":[[2020,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/bioinformatics\/btaa317","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.04.17.047449","asserted-by":"object"}]},"ISSN":["1367-4803","1367-4811"],"issn-type":[{"value":"1367-4803","type":"print"},{"value":"1367-4811","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,7]]},"published":{"date-parts":[[2020,7,1]]}}}